Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
Medreich Limited is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:India
Founded:2005
Employees:1,045
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Asia-Pacific
International Regulatory
EU GMP Certificates
16
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval LEUY0Q
EMA · #APR-7X0MDP98 · 2020-02-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-6TUNIJP8
Issued: 2020-09-18
Expires: 2025-12-02
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-L14YU6GJ
Issued: 2020-02-20
Expires: 2025-08-01
Loading CDMO intelligence...
Key facts about Medreich Limited
- Medreich Limited is headquartered in India.
- Medreich Limited was founded in 2005.
- Medreich Limited has 1,045 employees.
- Medreich Limited's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Medreich Limited
Directory pages this company appears in, each with the full list of matching manufacturers.